ECE2013 Poster Presentations Thyroid cancer (64 abstracts)
Thyroglobulin as an early marker of persistent/recurrent disease in patients with differentiated thyroid carcinoma (DTC)
Anna Masó Aulinas 1 , Cristina Comí Colom 2 , Lilian Mathison Mendoza 1 , Valeria Aragón Alcantara 1 , Eugenia Matute Mato 3 , Rosa Plà Corcoy 1, , Ignasi Saladich Gich 4 , Jose Espinosa Rodriguez 4 & Cintia Blanco González 1,
1Endocrinology and Nutrition Department. Santa Creu & Sant Pau Hospital, Barcelona, Spain; 2Endocrinology Unit, Dos de Maig Hospital, Barcelona, Spain; 3Biomedical Research Networking Centre on Bioengineering, Biomaterials & Nanomedicine: CIBER-BBN- EDUAB-HSP group, Spain; 4Clinical Epidemiology Department. Santa Creu & Sant Pau Hospital, Barcelona, Spain.
Introduction: Several clinical and molecular markers can be used to establish risk at the time of diagnosis in DTC. Thyroglobulin (Tg), which is essential in follow up, could be an early marker to identify risk patients. Around 25% of patients require 18 months or longer to have indetectable Tg. The presence of Tg antibodies (TgAb) invalidate the follow up of DTC via Tg and this is usually associated with a poor prognosis.
Aim: To evaluate the role of Tg after surgery and before radioiodine treatment, and the presence of TgAb as markers of persistent/recurrent disease in DTC.
Patients and methods: Retrospective study of 165 patients with DTC (1997–2010): women 78,2%, age at diagnosis 47.9+/- 16,26, medium follow up 4.8+/-3.74 years.
We performed a multivariate (logistic regression) analysis including Tg after surgery and before radioiodine treatment and other known prognostic variables. We divided Tg into tertile (cut-off: 1.7 ug/l, 13.6 ug/l) excluding TgAb positive at first before adding it later. We performed a ROC curve to identify cut-off level of Tg. Statistical analysis was performed with SPSS 19.0.
Results: In the multivariate analysis excluding TgAb positive, Tg in higher tertil is the unique predictive variable of persistent/recurrent disease at 18–24 months (RR 21.67). Adding positive TgAb, the predictive variables are Tg (RR 21, 04) and presence of TgAb (RR 112). The ROC curve shows a cut-off of Tg after surgery and before radioiodine treatment of 5,55 ug/l that identifies persistent/recurrent disease (S 81, E 57,5, NPV 92,5 and PPV 31,5% (AUC 0.809)).
Conclusions: In this serie, Tg value after surgery and before radioiodine treatment and the presence of TgAb are predictive variables of recurrent/persistent disease at 18–24 months. Tg has a predictive value and could be a useful marker to stratify risk at the time of diagnosis.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more